Literature DB >> 32274751

Ubiquitin-Regulated Cell Proliferation and Cancer.

Beatriz Pérez-Benavente1, Alihamze Fathinajafabadi Nasresfahani1, Rosa Farràs2.   

Abstract

Ubiquitin ligases (E3) play a crucial role in the regulation of different cellular processes such as proliferation and differentiation via recognition, interaction, and ubiquitination of key cellular proteins in a spatial and temporal regulated manner. The type of ubiquitin chain formed determines the fate of the substrates. The ubiquitinated substrates can be degraded by the proteasome, display altered subcellular localization, or can suffer modifications on their interaction with functional protein complexes. Deregulation of E3 activities is frequently found in various human pathologies, including cancer. The illegitimated or accelerated degradation of oncosuppressive proteins or, inversely, the abnormally high accumulation of oncoproteins, contributes to cell proliferation and transformation. Anomalies in protein abundance may be related to mutations that alter the direct or indirect recognition of proteins by the E3 enzymes or alterations in the level of expression or activity of ubiquitin ligases. Through a few examples, we illustrate here the complexity and diversity of the molecular mechanisms related to protein ubiquitination involved in cell cycle regulation. We will discuss the role of ubiquitin-dependent degradation mediated by the proteasome, the role of non-proteolytic ubiquitination during cell cycle progression, and the consequences of this deregulation on cellular transformation. Finally, we will highlight the novel opportunities that arise from these studies for therapeutic intervention.

Entities:  

Keywords:  Cancer; Cell cycle; E3 ligases; Eukaryotic ubiquitin conjugation; Non-proteolytic ubiquitination; Ubiquitin; Ubiquitin-dependent degradation

Mesh:

Substances:

Year:  2020        PMID: 32274751     DOI: 10.1007/978-3-030-38266-7_1

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  5 in total

1.  Lower expression of PDZRN3 induces endometrial carcinoma progression via the activation of canonical Wnt signaling.

Authors:  Qiuhong Li; Jie Zhong; Shangjie Yang; Yanping Liang
Journal:  Oncol Lett       Date:  2022-01-27       Impact factor: 2.967

2.  Hypoxia-inducible CircPFKFB4 Promotes Breast Cancer Progression by Facilitating the CRL4DDB2 E3 Ubiquitin Ligase-mediated p27 Degradation.

Authors:  Hang Chen; Rui Yang; Lei Xing; Bin Wang; Dawei Liu; Xiaoqiang Ou; Yumei Deng; Rong Jiang; Junxia Chen
Journal:  Int J Biol Sci       Date:  2022-06-06       Impact factor: 10.750

3.  Expression of colorectal neoplasia differentially expressed in anaplastic thyroid carcinoma and its effect on cancer cell proliferation.

Authors:  Lili Du; Qingsong Zhao; Jingjing Li; Mingli Wang; Hong Qiao
Journal:  Ann Transl Med       Date:  2022-04

4.  UBQLN4 is activated by C/EBPβ and exerts oncogenic effects on colorectal cancer via the Wnt/β-catenin signaling pathway.

Authors:  Xiaolong Tang; Yahang Liang; Guorui Sun; Qingsi He; Hui Qu; Peng Gao
Journal:  Cell Death Discov       Date:  2021-12-20

Review 5.  The Next Frontier: Translational Development of Ubiquitination, SUMOylation, and NEDDylation in Cancer.

Authors:  Nicole E Pellegrino; Arcan Guven; Kayleigh Gray; Punit Shah; Gargi Kasture; Maria-Dorothea Nastke; Anjan Thakurta; Stephane Gesta; Vivek K Vishnudas; Niven R Narain; Michael A Kiebish
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.